PPLPHARMA Shareholding Pattern: Promoter, FII & DII Holding (PPLPHARMA)

PPLPHARMA latest shareholding pattern: promoter holding, FII / FPI holding, DII and mutual fund holding, public holding and number of shareholders, quarter by quarter.

  • PPLPHARMA Financials
  • PPLPHARMA Shareholding Pattern
  • PPLPHARMA Earnings Documents
  • PPLPHARMA Announcements
  • PPLPHARMA Corporate Actions
  • PPLPHARMA Bulk, Block & Insider Deals
  • PPLPHARMA Delivery Data
  • PPLPHARMA Earnings Concalls
  • Market Timeline
  • Concall Monitor
  • Company Research
  • Earnings Monitor
  • Upcoming Results
  • Sector Monitor
  • Sector Performance
  • Bulk & Block Deals
  • Delivery Data
  • FII & DII Activity
  • Market Indices
  • Plans & Pricing

Piramal Pharma Ltd (PPLPHARMA) Shareholding Pattern - Promoter, FII, DII & Public Holdings

As of Sep 2026, promoters held 34.8% of Piramal Pharma Ltd, FIIs 13.65%, DIIs 14.43%, government - and the public 36.72%, across 4,13,197 shareholders.

PPLPHARMA shareholding pattern, quarterly (%)
MetricDec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
Promoters34.94%34.94%34.85%34.85%34.85%34.85%34.8%34.8%
FIIs31.68%31.49%30.86%30.27%29.66%30.17%12.51%13.65%
DIIs14.09%14.78%14.25%14.89%15.68%15.61%14.57%14.43%
Public18.85%18.42%19.46%19.46%19.35%19.01%37.62%36.72%
No. of Shareholders4,18,4424,32,8434,58,4304,62,5114,53,8304,50,6614,61,0964,13,197
Others0.40.340.570.510.440.340.480.4
PPLPHARMA shareholding pattern, yearly (%)
MetricMar 2023Mar 2024Mar 2025Mar 2026Sep 2026
Promoters34.78%35.02%34.94%34.85%34.8%
FIIs39.28%30.58%31.49%30.17%13.65%
DIIs4.98%12.12%14.78%15.61%14.43%
Public20.57%21.89%18.42%19.01%36.72%
No. of Shareholders2,41,3592,97,9964,32,8434,50,6614,13,197
Others0.390.370.340.340.4
  • PPLPHARMA Financials
  • PPLPHARMA Earnings Concalls
  • PPLPHARMA Growth Catalysts
  • PPLPHARMA Corporate Actions
  • PPLPHARMA Announcements
  • PPLPHARMA Results & Documents
  • PPLPHARMA Bulk & Block Deals
  • PPLPHARMA Delivery Data